Case Studies
Learn more about Biointelect’s diverse work and the profound impact we are making for clients and beyond through our recent project case studies.
Filter
Studies
Horizon Scanning in the New Zealand Health System
Horizon scanning is a process or system which seeks to systematically and proactively identify current, new, and emerging health technologies
Economic Importance of the Macquarie Park Innovation District in the Local, State, and National Economy
Macquarie Park Innovation District (MPID) is Australia’s first innovation district, home to the world class Macquarie University, headquarters of multi-national
Pioneering A New Children’s Food Allergy Treatment
With the evolution of biotechnology, addressing allergy treatments for children offers hope for a future where the young can lead
Nanoparticle Drug Reformation: A Biointelect Product Development Strategy
With oncology treatments rapidly growing in interest, the quest to refine and perfect drug delivery mechanisms is paramount. Utilising nanoparticles,
A Regulatory Strategy For Innovative Drug Device Combination
In the realm of drug and device regulations, having a partner to navigate the complexities can significantly alter a company’s
HTA Roadmap For a New Vaccine in Australia
The landscape of vaccines in Australia is marked by stringent guidelines and a competitive marketplace and above all a focus
Streamlining Quality & Safety: Development in QMS and Pharmacovigilance
In the rapidly evolving world of biotech, adhering to global quality and safety standards is paramount.
A US-based biotech
Navigating European Market Access: A Strategic Blueprint for Novel Vaccines
Introduction The European medical market is the second-largest medical device market following the US, requiring newfound innovation for pharmaceutical companies
Developing a Winning Business Case: Securing NHMRC Grant for an Antibiotic Solution
Antibiotic resistance is a looming global health challenge, with the ESKAPE pathogens leading the charge. Amid this urgent need, a
Advancing Viral Vector Manufacturing: The NSW VVMF Initiative
Introduction As the world delves deeper into the complexities of biotechnology, the need for innovative facilities that can accelerate this
Innovating the RNA Landscape: A Case Study Of The NSW RNA Pilot Manufacturing Facility
In an era of rapid advancements in medical technology, the journey to propel RNA therapeutics to the forefront of healthcare
This summary explores how antimicrobial resistance (AMR) is framed within Health Technology Assessment (HTA) frameworks worldwide and Australia’s unique role...
There is an identified need in Australia’s Vaccine Value Chain to boost vaccine development, translation, commercialisation and access. Globally, there...
Horizon scanning is a process or system which seeks to systematically and proactively identify current, new, and emerging health technologies...
Macquarie Park Innovation District (MPID) is Australia’s first innovation district, home to the world class Macquarie University, headquarters of multi-national...
Driving more efficient and accelerated results from pre-clinical trials to commercialisation of new therapies for Australian, European and U.S. firms....
With the rapid and ongoing global growth of cell and gene (C&G) products, there is an opportunity for Australia to...
